ExodusPoint Capital Management LP Sells 32,779 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
otakuyassine3@gmail.com ExodusPoint Capital Management LP cut its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL –...
Biosciences
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Bought by ExodusPoint Capital Management LP
ExodusPoint Capital Management LP lifted its stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT –...
Norges Bank Purchases Shares of 520,810 IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Norges Bank acquired a new position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free...
Corebridge Financial Inc. Sells 2,442 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Corebridge Financial Inc. cut its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free...
Natixis Advisors LLC Makes New $395,000 Investment in Avidity Biosciences, Inc. (NASDAQ:RNA)
Natixis Advisors LLC bought a new stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA –...
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. raised its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free...
Steward Partners Investment Advisory LLC Sells 45,168 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Steward Partners Investment Advisory LLC trimmed its holdings in shares of Avidity Biosciences, Inc. (NASDAQ:RNA...
Neurocrine Biosciences (NASDAQ:NBIX) Given New $163.00 Price Target at Guggenheim
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price target decreased by stock analysts...
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Sells $93,007.67 in Stock
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Ingrid Delaet sold 623 shares of...
Canaan Partners XI LLC Has $58.10 Million Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Canaan Partners XI LLC lowered its stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA –...
Arcus Biosciences (NYSE:RCUS) Trading Down 4.5% – What’s Next?
Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report)’s stock price dropped 4.5% during trading on...